These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25447618)

  • 21. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.
    Naccarelli GV; Panaccio MP; Cummins G; Tu N
    Am J Cardiol; 2012 May; 109(10):1526-33. PubMed ID: 22360819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
    Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CHADS2 Components Are Associated with Stroke-Related In-hospital Mortality in Patients with Atrial Fibrillation.
    Yaghi S; Sherzai A; Pilot M; Sherzai D; Elkind MS
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2404-7. PubMed ID: 26231476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation.
    Barnes ME; Miyasaka Y; Seward JB; Gersh BJ; Rosales AG; Bailey KR; Petty GW; Wiebers DO; Tsang TS
    Mayo Clin Proc; 2004 Aug; 79(8):1008-14. PubMed ID: 15301328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased red blood cell distribution width might predict left ventricular hypertrophy in patients with atrial fibrillation.
    Yao HM; Wang XL; Peng X; Chen SY; Wan X; Zuo W; Gan X
    Medicine (Baltimore); 2020 Sep; 99(37):e22119. PubMed ID: 32925759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Red cell distribution width as a novel predictor for clinical outcomes in patients with paroxysmal atrial fibrillation.
    Lee KH; Park HW; Cho JG; Yoon NS; Kim SS; Kim MR; Kim MC; Cho KH; Kim HK; Kim CH; Kim KH; Jun SJ; Kim WJ; Lee KJ; Jeong HC; Cho JY; Park KH; Sim Ds; Yoon HJ; Kim KH; Hong YJ; Kim JH; Ahn Y; Jeong MH; Park JC
    Europace; 2015 Oct; 17 Suppl 2():ii83-8. PubMed ID: 26842121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
    Lip GY; Connolly S; Yusuf S; Shestakovska O; Flaker G; Hart R; Lanas F; Xavier D; Eikelboom J;
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):31-8. PubMed ID: 23390125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study.
    Arbel Y; Weitzman D; Raz R; Steinvil A; Zeltser D; Berliner S; Chodick G; Shalev V
    Thromb Haemost; 2014 Feb; 111(2):300-7. PubMed ID: 24173039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population.
    Poli D; Lip GY; Antonucci E; Grifoni E; Lane D
    J Cardiovasc Electrophysiol; 2011 Jan; 22(1):25-30. PubMed ID: 20653814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.
    Barnes GD; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Besley D; Krol GD; Froehlich JB; Kaatz S
    Thromb Res; 2014 Aug; 134(2):294-9. PubMed ID: 24929840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation.
    Aakre CA; McLeod CJ; Cha SS; Tsang TS; Lip GY; Gersh BJ
    Stroke; 2014 Feb; 45(2):426-31. PubMed ID: 24309585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.
    Olesen JB; Lip GY; Lane DA; Køber L; Hansen ML; Karasoy D; Hansen CM; Gislason GH; Torp-Pedersen C
    Am J Med; 2012 Aug; 125(8):826.e13-23. PubMed ID: 22579139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L
    Int J Cardiol; 2013 Sep; 167(6):2682-7. PubMed ID: 22795403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study).
    Azarbal F; Welles CC; Wong JM; Whooley MA; Schiller NB; Turakhia MP
    Am J Cardiol; 2014 Apr; 113(7):1166-72. PubMed ID: 24507169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged atrium electromechanical interval is associated with stroke in patients with atrial fibrillation after catheter ablation.
    Chao TF; Lin YJ; Tsao HM; Chang SL; Lo LW; Hu YF; Tuan TC; Li CH; Chang HY; Wu TJ; Yu WC; Chen SA
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):375-80. PubMed ID: 23252831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification schemes, anticoagulation use and outcomes: the risk--treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation.
    Sandhu RK; Bakal JA; Ezekowitz JA; McAlister FA
    Heart; 2011 Dec; 97(24):2046-50. PubMed ID: 22076011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.